A. MENARINI I.F.R. S.r.l.
Via Sette Santi, 3 50131 Firenze ITALY
Telephone: 0039 055 5680260
Fax: 0039 055 5680446
Web site: www.menarini.com
Contact: Dr. Marco Criscuoli (Licensing Director)

At a Glance
Status: Big Pharma
Date of foundation: 1886
Employees: 12.450
Turnover: 2.403.000.000 Euro
% Export: 56 %
Export destinations: Worldwide.

Main Activity

The Menarini Group is a European, medium sized privately owned pharmaceutical company, headquartered in Italy, where it was founded in 1886. With an annual turnover of over 2,4 billion euros, Menarini is characterized by very strong marketing skills and a 30 year-long history of pharmaceutical research.
Many European, American and Japanese companies have consolidated licensing and co-marketing agreements with Menarini, characterized by continuous exchange of know-how and expertise between partners.
Menarini’s products – either coming from co-marketing alliances or from its own R&D – are now marketed in over 100 countries, in most of which Menarini established dynamic and efficient subsidiaries. In particular, Menarini has the coverage of entire European territory (Western, Central, Eastern Europe plus the CIS countries and Turkey).
Menarini performs research, from drug design to phase III clinical studies, at its six Research Centres in Europe. The largest of these centres, the Pomezia Campus near Rome (Italy), also hosts Menarini Biotech, the group subsidiary devoted to biotechnology.
Menarini Biotech’s mission is to be a world class development and manufacturing organization for biologic medicines.
Menarini biotech’s current technologies allow it to develop the manufacturing process of third parties’ compounds, and produce clinical and marketing supplies of new biotech products (rDNA, MABs and similar) on a contract manufacturing basis, as well as to establish strategic alliances for biotech research collaborations.

Company Strengths

HIGH QUALITY PRODUCTS: last generation prescription drugs in main therapeutic classes.
INNOVATIVE ROCESSES/SERVICES/PRODUCTS: Menarini produces clinical and marketing supplies of new biotech products (rDNA, MABs and similar).
NETWORKING: Many European, American and Japanese companies have consolidated licensing and co-marketing agreements with Menarini. The company has dynamic and efficient subsidiaries in many countries, included the entire European territory.
R & D CAPACITY: Menarini has six Research Centres in Europe, the largest is the Pomezia Campus near Rome (Italy). The six centres employ 750 and their focus in on oncology, cardiovascular and inflammatory diseases.

Customer References

• Big Pharma
• biotech companies
• government agencies
• academia